Hematologic Malignancies
Research activity includes chronic myeloid leukemia, with interest in treatment strategies aimed at molecular remission and disease control after targeted therapy.
- BCR-ABL1-directed therapy
- Deep molecular response
- Stem cell persistence
Clinical work in this area also extends to combination approaches involving tyrosine kinase inhibitor discontinuation and targeted agents.
Neurology and Immune-Mediated Disease
The sponsor supports studies in autoimmune encephalitis, reflecting a focus on severe inflammatory disorders of the central nervous system with autoantibody-positive disease patterns.
- Autoimmune encephalitis
- Neuroimmunology
- Autoantibody-associated inflammation
These investigations address neurological dysfunction linked to immune dysregulation and acute clinical deterioration.
Cardiology and Heart Failure
Research includes acute decompensated heart failure, with attention to patients hospitalized for worsening cardiac function and associated renal complications.
- Heart failure
- Cardiorenal dysfunction
- Hospital-based cardiovascular care
Clinical interests also cover outcomes related to mortality, rehospitalization, and renal decline in advanced heart failure.
Critical Care and Infectious Disease
The trial portfolio includes sepsis, septic shock, and ventilated patients with pneumonia and herpes simplex virus type 1 detection in the lower respiratory tract.
- Intensive care unit infections
- Sepsis and septic shock
- Viral respiratory infection
These studies reflect engagement with severe infection syndromes managed in critical care settings.
Gastroenterology and Genitourinary Oncology
Additional research spans active ulcerative colitis, prostate cancer, and translational interest in the gut microbiome alongside advanced cancer care.
- Ulcerative colitis
- Prostate cancer
- Faecal microbiota
Work in this domain connects inflammatory bowel disease with microbiome-based interventions and oncologic management in prostate malignancy.
